Santen Pharmaceutical : Announces Change of Representative Director of the Board
March 25, 2024 at 03:07 am EDT
Share
March 25, 2024
Santen Announces Change of Representative Director of the Board
Santen Pharmaceutical Co., Ltd. (Head Office: Osaka; President and CEO: Takeshi Ito) announced the change of Representative Director of the Board today. This change was made as the Board received offer from Akira Kurokawa, Representative Director of the Board, Chairman, to resign from his position as Representative Director of the Board.
(1) Reason for change (resignation)
Completion of strengthening the Company's execution capabilities since the change in June 2022.
(2) Details of the change (As of April 1, 2024)
Name
Newly Appointed
Current Position
Akira Kurokawa
Director of the Board,
Chairman
Representative Director of the
Board, Chairman
Akira Kurokawa continues to be assigned as chair of Board of Directors.
Takeshi Ito (Representative Director of the Board, President and Chief Executive Officer) is the only Representative Director of the Board of the Company after this change.
Contact:
Guillaume Sakuma
Global Head of IR, IR Group E-mail:ir@santen.com
About Santen
As a specialized company dedicated to eye health, Santen aspires to contribute to the realization of "Happiness with Vision" by providing products and services to patients, consumers, and medical professionals around the world. Since its establishment, and guided by its CORE PRINCIPLE, "Tenki ni sanyo suru," Santen has been committed to helping people maintain and improve their eye health for more than 130 years. Santen is engaged in the global research and development, manufacturing, and sales and marketing of pharmaceutical products in the field of eye care, supporting the eye health of approximately 50 million people in more than 60 countries and regions worldwide. Santen's missionis to provide essential and significant value to patients and society in the prevention, diagnosis, and treatment of eye diseases through products and services created from its expertise in the ophthalmology field and from the patient's perspective. To create a future in which as many patients as possible can lead happy and fulfilling lives, Santen is committed to doing its utmost to realize a society in which people around the world can experience "Happiness with Vision."
For more information, please visit Santen's websitehttps://www.santen.com/en.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Santen Pharmaceutical Co. Ltd. published this content on
25 March 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
25 March 2024 07:06:08 UTC.
SANTEN PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and sales of pharmaceutical products. The Company has medical pharmaceutical business, OTC drugs business, medical devices business and other businesses. The Company engages in manufacture, sale and clinical development of medical pharmaceutical products, the development, manufacturing and sales of medical equipment, as well as the cleaning business. The Company operates in Japan, Europe, Asia, North America markets.